Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo

B lymphocyte-induced maturation protein-1 (Blimp-1) is a transcriptional repressor that is sufficient to trigger terminal differentiation in the B cell lymphoma BCL-1, In this study, we have determined the expression pattern of Blimp-1 in vivo In primary and secondary lymphoid organs of humans and immunized mice. Blimp-1 is expressed In plasma cells derived from either a T-independent or T-dependent response in plasma cells that have undergone isotype switching and those resulting front secondary immunization, Blimp-1 is also present in long-lived plasma cells residing in the bone marrow. However, Blimp-1 was not detected in memory B cells, This expression pattern provides further evidence of a critical role for Blimp-1 in plasma cell development, supporting earlier studies in cultured lines. Significantly, Blimp-1 was also found in a fraction (4-15%) of germinal center B cells in murine spleen and human tonsils, Blimp-1 expression in the germinal center is associated with an interesting subset of cells with a phenotype intermediate between germinal center B cells and plasma cells, In the mouse, Blimp-1(+) germinal center B tells peak at day 12 postimmunization and disappear soon thereafter, They are not apoptotic, some are proliferating, they express germinal center markers peanut agglutinin or CD10 but not Bcl-6, and most express CD138 (syndecan-1), IRF4, and cytoplasmic Ig, Together, these data support a model in which B cell fate decisions occur within the germinal center and Blimp-1 expression is critical for commitment to a plasma cell, rather than a memory cell, fate.